Qureight is a Cambridge-based Core Imaging Laboratory specializing in AI-driven data curation to expedite drug development. Collaborating with biopharmaceutical companies, contract research organizations, and hospitals, Qureight focuses on lung and heart diseases, aiming to reduce clinical trial durations and costs.
Their platform integrates complex healthcare data, including clinical images, physiological metrics, and biomarkers, to provide real-time, actionable insights for pharmaceutical clients.Founded by medical professionals and engineers, Qureight employs machine learning algorithms for CT scan analysis and AI-assisted workflows to enhance decision-making in clinical trials.
Their technology facilitates collaborative analysis, enabling healthcare institutions to work together on complex research challenges. By structuring and analyzing data effectively, Qureight supports the development of new treatments for conditions like interstitial lung diseases, pulmonary hypertension, and lung cancer.
